Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Study Finds Broad Therapeutic Potential for Nanoparticles
Scientific Advances

Study Finds Broad Therapeutic Potential for Nanoparticles

By Will DossApr 7, 2020
Share
Facebook Twitter Email
Chad Mirkin, PhD, professor of Medicine in the Division of Hematology and Oncology and the George B. Rathmann Professor of Chemistry at Northwestern’s Weinberg College of Arts and Sciences, was senior author of the study published in the journal ACS Nano.

Spherical nucleic acids, structures made from short snippets of DNA radially arranged around a nanoparticle core, have the ability to travel to different organs in the body depending on the type of hydrophobic “tail” used to anchor it to the particle surface, according to a recent Northwestern study published in the journal ACS Nano.

These nanoparticles can target genetic drivers of disease-causing proteins, so these findings give scientists a broad template for exploring organ-specific therapies, according to Chad Mirkin, PhD, professor of Medicine in the Division of Hematology and Oncology, the George B. Rathmann Professor of Chemistry at Northwestern’s Weinberg College of Arts and Sciences, and senior author of the study.

“How these spherical nucleic acids are made dictates where they go and what organs they access,” said Mirkin, who is also a member of the Robert H. Lurie Comprehensive Cancer Center at Northwestern University. “Once you understand this, you realize that there is an enormous amount of design space.”

While nucleic acids in linear form do not readily enter cells, the equivalent sequence arranged in an SNA architecture will be rapidly internalized by cells. This uptake is likely due to SNAs’ greater physical resemblance to molecules called G-quadraplexes that are often internalized by cells.

“You can move constructs into cells and you can use that capability to make measurements in cells, or you can use such structures to regulate what goes on in the cell,” Mirkin said. “The latter is how we develop therapeutics.”

SNAs comprised of DNA with a lipid tail anchor direct DNA accumulation (magenta) to the kidneys. Provided by Chad Mirkin, PhD.

In the current study, investigators compared SNAs with two different types of “tails” on the ends of short DNA strands: a cholesterol tail and a lipid tail. The difference between each DNA “tail” was its ability to bind to the particle surface and interact with neighboring tails, which determines the release rate of the DNA sequence from the SNA’s nanoparticle core. Injecting these SNAs into mice, the scientists found SNAs with cholesterol tail DNA accumulated in greater amounts in the lungs, while SNAs with lipid tail DNA accumulated in greater amounts in the kidneys. These differences in DNA distribution highlight how changing the release rate of DNA from the SNA’s nanoparticle core can dictate what organs and cells the associated DNA reaches, according to Mirkin.

“Depending on whether you want to treat kidney disease or you want to treat lung disease, different constructs can be designed to yield greater or less accumulation,” Mirkin said.

Mirkin noted that the behavior of kidney-specific SNAs has sparked discussion with Northwestern Medicine nephrologists about future collaboration on therapies.

“With the conventional constructs that didn’t go into the kidney, that would be a silly choice,” Mirkin said. “Until you do this study, you don’t know how to design spherical nucleic acids to fully maximize their potential in a given organ of interest.”

Mirkin noted that adding these tails are not the only modification needed to deliver SNAs to a specific organ. Sending SNAs to the lungs could be enhanced through the use of a nebulizing spray to coat the lungs, while kidney-focused SNAs would need to be designed to get “stuck” in the kidney’s filtration system to enable uptake of theraptutics, because the nanoparticles are too big to enter the kidneys.

In any case, these discoveries, in conjunction with other recent studies demonstrating that tweaking SNA structure can direct them to enter the brain or penetrate through the skin, present Mirkin and his cast of collaborators with a wealth of opportunity. To sift through these options, Mirkin said he is now developing high-throughput screening methods to codify and test the “design rules” for SNAs, to establish a database of characteristics and materials from which organ-specific SNAs could be designed.

“If we want to optimize them for the kidney or the brain, what are the specific features that will get them there?” Mirkin said. “You have to reduce the number of shots on goal required, so now we’re creating assays that will do just that.”

Jason Werthheim, MD, PhD, the Edward G. Elcock Professor of Surgical Research and vice chair for research in the Department of Surgery, and Zheng Zhang, MD, research professor of Surgery in the Division of Organ Transplantation, were both co-authors of the study.

Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health grants U54CA199091, R01CA208783 and P50CA221747

Cancer Neurology and Neuroscience Research
Share. Facebook Twitter Email

Related Posts

Investigating Protein’s Role in Hearing Loss

Mar 27, 2023

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Comments are closed.

Latest News

Investigating Protein’s Role in Hearing Loss

Mar 27, 2023

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023

How ChatGPT Has, and Will Continue to, Transform Scientific Research

Mar 21, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230317_NM651
20230317_NM610
20230317_NM569
20230317_NM537
20230317_NM331
20230317_NM323
20230317_NM316
20230317_NM336
20230317_NM626
20230317_NM662
20230317_NM655
20230317_NM642

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.